List of Top 

Mid Cap Companies

Read More Read Less
Sensex 77414.92
191.51 (-0.25%)

Mid cap companies in India are ones with market capitalization (cap) between Rs. 5000 to Rs. 20000 crores. As the name goes, mid cap companies fall right in between large and small cap companies. Mid cap stocks are situated in the ideal sweet spot asthey offer investors with greater growth potential than large cap stocks but also offer less volatility and risks than small cap stocks. Moreover, they're also usually cost effective for the investors. In a nutshell, mid cap stocks offer a best of both worlds: high growth but less volatility.

MoneyWorks4Me can help you identify the best mid cap stocks to invest in. By finding out the mid cap stocks with higher growth potential, you can balance your investment portfolio and increase your chances of earning higher returns.
Below is a list of all mid cap companies in India that you can choose from. There are several filters for you to choose from. Starting by sorting the mid cap stocks based on our 10 Year X-ray colour codes can help you choose investment worthy companies, and avoiding companies with riskier businesses.
Sorting by market cap allows you to avoid smaller companies with higher risk. You can also sort using valuation multiples like price to earnings (P/E) and price to book value (P/BV). This allows you to identify a list of undervalued or fair valued stocks. Finally, sorting by price change allows you to know which mid cap are in demand on that particular day.

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen:- Q: Quality, V: Valuation,PT: Price Trend

Mid Cap Companies as on Mar-2025 |
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks


Company Name (M.Cap)
DeciZen


CMP


Price
Change


Market
Cap (Cr)


52 Week
High


52 Week
Low


ROE  


P/E Ratio


P / BV


EV/
EBITDA


5Y Sales
Gr.(%)


5Y Profit
Gr.(%)
More Info
1
Q V PT
13,604 5.63% 44,158 17,748
26 Jul, 24
12,140
27 Mar, 25
79.20 61.68 46.69 40.31 7.37 9.95
2
Q V+ PT
698.5 4.13% 52,734 744.0
30 Dec, 24
406.4
04 Jun, 24
2.19 302.46 5.78 114.90 12.47 10.01
3
Q V+ PT
202.7 3.63% 28,378 285.3
02 Sep, 24
153.2
21 Nov, 24
22.41 18.90 2.89 10.78 19.42 17.31
4
Q V PT
1,050 3.52% 27,558 1,430
09 Aug, 24
890.3
27 Mar, 25
24.92 66.13 13.56 33.66 14.82 22.39
5
Q V PT
28,852 3.42% 32,502 41,000
01 Aug, 24
25,714
03 Mar, 25
25.06 58.53 18.27 39.17 6.93 10.29
6
Q V PT
350.2 3.35% 27,246 514.0
22 Apr, 24
267.2
04 Mar, 25
28.61 159.31 3.39 27.87 6.88 21.16
7
Q V+ PT
2,382 2.78% 95,621 2,445
20 Mar, 25
1,500
01 Apr, 24
17.86 20.13 3.54 12.13 12.93 15.43
8
Q V PT
4,637 2.67% 50,863 5,529
27 Sep, 24
3,739
12 Aug, 24
13.55 31.90 3.92 11.54 14.49 4.33
9
Q V+ PT
11,242 2.66% 1,01,732 13,300
11 Jul, 24
7,890
04 Jun, 24
29.01 134.66 35.63 91.81 17.45 24.67
10
Q V PT
1,459 2.47% 48,260 1,946
20 Sep, 24
1,103
01 Apr, 24
4.45 67.33 7.49 38.02 11.87 -13.73
11
Q V+ PT
6,622 2.30% 95,219 7,545
08 Nov, 24
5,691
04 Jun, 24
13.81 79.24 11.16 42.37 -2.69 26.09
12
Q V PT
165.4 2.16% 43,166 310.0
15 Jul, 24
137.0
17 Mar, 25
17.28 28.14 4.42 12.45 19.71 7.87
13
Q V+ PT
1,311 2.16% 46,947 1,795
05 Jul, 24
842.1
15 Apr, 24
17.68 83.00 12.15 52.43 -5.05 7.35
14
Q V+ PT
1,501 2.15% 38,089 1,758
03 Jan, 25
1,061
28 Jun, 24
9.67 48.80 5.44 25.49 11.18 4.98
15
Q V+ PT
662.9 2.14% 41,383 1,187
21 Jun, 24
580.7
04 Jun, 24
23.55 0.00 31.56 157.54 20.93 0.00
16
Q V+ PT
260.6 2.00% 33,564 404.0
08 Aug, 24
231.6
17 Feb, 25
6.84 27.63 3.60 12.43 11.32 1.77
17
Q V PT
477.8 1.89% 48,184 794.6
02 Jan, 25
337.0
04 Jun, 24
14.11 75.92 10.56 37.19 16.21 75.71
18
Q V PT
424.4 1.75% 73,685 525.0
20 Dec, 24
280.2
15 Apr, 24
17.16 9.81 1.63 10.33 0.00 19.38
19
Q V+ PT
203.6 1.62% 39,918 353.9
12 Jul, 24
158.9
03 Mar, 25
13.21 14.89 2.24 8.78 6.98 12.41
20
Q V+ PT
4,932 1.55% 38,109 5,110
28 Mar, 25
3,639
04 Jun, 24
16.82 55.34 6.74 22.13 16.99 20.93
21
Q V+ PT
1,448 1.54% 37,005 2,977
08 Jul, 24
885.4
01 Apr, 24
16.42 46.31 6.79 27.98 5.25 10.14
22
Q V+ PT
2,877 1.43% 48,743 3,088
22 Aug, 24
1,825
15 Apr, 24
37.27 56.73 25.62 38.52 2.00 8.94
23
Q V+ PT
360.4 1.42% 73,341 647.0
15 Jul, 24
220.0
15 Apr, 24
19.69 56.38 8.11 33.16 16.80 18.29
24
Q V+ PT
1,809 1.42% 65,500 2,030
04 Sep, 24
1,170
04 Jun, 24
7.72 57.00 5.84 32.92 20.04 51.50
25
Q V+ PT
728.4 1.36% 58,176 1,148
22 May, 24
655.7
03 Mar, 25
40.55 46.88 15.05 32.28 0.00 0.00
26
Q V PT
2,797 1.31% 53,612 4,807
23 Oct, 24
2,408
28 Feb, 25
14.43 65.77 9.55 23.31 23.95 22.27
27
Q V PT
1,540 1.27% 43,458 1,830
15 Oct, 24
958.0
01 Apr, 24
-14.66 0.00 4.94 13.63 3.67 -213.18
28
Q V+ PT
2,001 1.27% 52,901 2,299
03 Feb, 25
1,737
01 Apr, 24
10.04 124.38 12.41 62.09 4.64 -6.22
29
Q V PT
30,502 1.23% 1,10,053 31,215
28 Mar, 25
23,500
12 Nov, 24
12.83 84.53 5.28 25.61 10.81 15.21
30
Q V+ PT
6,250 1.23% 53,306 9,909
22 May, 24
5,389
28 Jan, 25
12.89 122.76 14.56 64.82 4.79 61.53
31
Q V PT
160.4 1.20% 25,470 309.9
26 Jul, 24
135.8
03 Mar, 25
6.66 25.75 1.14 42.28 0.00 18.84
32
Q V PT
1,834 1.20% 34,127 2,064
03 Apr, 24
1,602
13 Mar, 25
4.81 60.62 1.94 15.21 9.15 26.18
33
Q V PT
176.8 1.03% 51,195 229.9
23 Aug, 24
149.7
04 Jun, 24
2.26 970.87 38.44 113.24 40.68 0.00
34
Q V PT
114.8 0.88% 47,439 175.7
22 May, 24
99.20
12 Feb, 25
6.39 23.94 0.87 6.98 9.49 5.80
35
Q V PT
4,490 0.78% 47,655 5,990
29 Aug, 24
4,228
04 Jun, 24
25.76 36.76 8.02 21.78 13.69 12.07
36
Q V PT
692.1 0.71% 27,514 1,147
04 Apr, 24
626.9
17 Mar, 25
21.88 42.64 8.13 25.88 11.70 14.99
37
Q V PT
4,105 0.70% 85,799 4,862
16 Oct, 24
3,419
04 Jun, 24
29.51 36.30 11.53 26.86 6.18 15.11
38
Q V PT
77.68 0.65% 83,525 108.0
29 Jul, 24
65.89
13 Jan, 25
14.19 11.59 1.72 8.52 19.08 0.00
39
Q V PT
1,167 0.63% 55,786 1,826
21 Jun, 24
1,002
28 Feb, 25
13.25 62.32 6.10 21.64 9.10 -1.61
40
Q V+ PT
13,608 0.60% 79,389 19,150
17 Dec, 24
7,100
15 Apr, 24
14.58 240.00 46.97 279.61 20.48 26.17
41
Q V PT
186.2 0.54% 48,204 246.9
20 Jun, 24
148.8
17 Feb, 25
14.76 12.98 1.64 8.51 17.49 26.50
42
(M)
Q V PT
68.88 0.50% 60,558 95.45
21 May, 24
59.70
13 Jan, 25
23.92 9.35 1.96 5.19 11.89 5.49
43
Q V+ PT
30,731 0.48% 65,300 31,900
04 Mar, 25
25,200
25 Apr, 24
34.87 48.93 16.82 34.21 9.72 21.88
44
Q V+ PT
1,980 0.46% 58,339 2,032
24 Mar, 25
1,071
25 Apr, 24
19.21 35.42 5.47 19.85 10.77 14.35
45
Q V PT
1,974 0.43% 27,675 3,059
14 Jun, 24
1,680
04 Mar, 25
16.05 40.29 6.62 22.97 7.76 9.19
46
Q V+ PT
651.5 0.36% 84,395 736.1
01 Feb, 25
490.7
04 Apr, 24
39.15 52.62 16.63 36.54 5.65 6.58
47
(M)
Q V PT
2,027 0.36% 92,523 2,403
02 Jan, 25
1,494
04 Jun, 24
14.31 32.25 5.61 18.39 6.41 36.90
48
Q V+ PT
556.9 0.32% 39,769 755.0
19 Sep, 24
479.0
18 Mar, 25
15.52 20.16 2.41 10.18 36.31 33.19
49
Q V PT
2,891 0.26% 27,623 5,040
14 Jun, 24
2,765
20 Mar, 25
20.03 43.27 4.91 28.14 13.88 20.21
50
Q V PT
360.1 0.15% 76,634 457.2
05 Sep, 24
287.6
03 Mar, 25
40.82 12.71 1.57 8.22 9.51 19.52
Prev 1

Mid Cap - Today's Top Gainers

Company Name CMP Price Change(%)
13,603.505.63%
698.504.13%
202.703.63%
1,050.253.52%
28,852.153.42%

Mid Cap - Today's Top Losers

Company Name CMP Price Change(%)
878.25-4.07%
5,216.30-3.73%
55.16-3.16%
636.20-3.03%
5,537.60-2.90%

News about Mid Cap Stocks in India

Glenmark Pharmaceuticals informs about disclosure

Glenmark Pharmaceuticals has informed that IGI Inc., wholly owned subsidiary of Glenmark Pharmaceuticals (the Company) has announced its plans to cease all CMC development and clinical supplies manufacturing at its facility in La Chaux-de-Fonds, Switzerland. In accordance with the Listing Regulations and SEBI Circular No SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, regarding the disclosure by listed entities under Regulation 30 of the Listing Regulations, we are providing the details of the intended closure of the aforementioned manufacturing facility herein below: Date of such binding agreement, if any, entered for sale of such unit/division, if any - Not Applicable ; Amount & percentage of turnover or revenue or income and net worth of the listed entity contributed by such unit or division during the last financial year – Turnover of plant - Rs. NIL (material is only used for captive consumption) Percentage to consolidated turnover of Company (1 April 2023 to 31 March 2024): NA Net worth of plant - Rs. 223.52 million (as of 31 March 2024); Estimated date of closure - 31 July 2025; Reasons for closure - IGI is progressing its pipeline and it is anticipated that higher quantities of finished product will be required for future clinical programs. IGI CMC development and manufacturing of ongoing and future clinical programs will be moved to a network of well-established Contract Development and Manufacturing Organizations (CDMOs); This closure will not adversely affect the Consolidated financials of the Company.

The above information is a part of company’s filings submitted to BSE.

29 Mar, 2025

GlaxoSmithKline Pharmaceuticals informs about postal ballot notice

GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of Postal Ballot Notice pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which is being sent to the Members of the Company, seeking their approval for re-appointment of Juby Chandy as a Whole-time Director & Chief Financial Officer & Appointment of Somasundaram Palamadairamaswamy & Anup Wadhawan as an Independent Directors. In compliance with the Circulars of the Ministry of Corporate Affairs, the said Notice is being sent electronically only to those Members, whose names appear in the Register of Members/ List of Beneficial Owners as received from National Securities Depository (‘NSDL’)/ Central Depository Services (India) (‘CDSL’) and who have registered their e-mail addresses in respect of electronic holdings with NSDL/CDSL through the concerned Depository Participants and in respect of physical holdings with the Company’s Registrar and Share Transfer Agent (RTA) i.e. KFin Technologies (‘KFintech’) as on Friday, 21st March, 2025 (cut-off date). The e-voting shall commence on Monday, 31st March, 2025 at 09.00 am (IIST) till Tuesday, 29th April 2025 at 5.00 PM (IST). The copy of the said Notice is also available on the website of the Company at https://india-pharma.gsk.com/en-in/investors/shareholder-information/postal-ballot/ and on the website of Kfintech https://evoting.kfintech.com/.

The above information is a part of company’s filings submitted to BSE.

28 Mar, 2025

How to pick best growth stocks?

Mid Cap Stocks FAQs

Mid cap companies as the name indicates, fall right in the middle, between large and small cap companies. At present, companies with a market capitalisation between Rs. 5,000 crore and Rs. 20,000 crore are considered as mid cap companies.

The appealing feature of mid cap companies as far as investors are concerned is that they offer higher growth as compared to large cap stocks and lower volatility than small cap stocks. Mid cap stocks provide a good diversification to an investor’s portfolio.

NIFTY Mid Cap 100, launched on April 1, 2006 is an index that captures the price of movement of 100 best mid cap stock companies listed on the National Stock Exchange representing the mid cap segment of the market.

The NIFTY Mid Cap 100 Index has all companies from NIFTY Mid Cap 50 and the remaining 50 stocks are taken from the NIFTY Mid Cap 150 Index based on the average daily turnover in the index. A few important points of the index are:

  1. Free-float market capitalisation method is used to calculate the NIFTY Mid Cap 100 Index
  2. The base date is April 1, 2005 and base value is 1000.
  3. Calculation frequency is on a daily basis and the index re-balancing is done semi-annually.
The benefits of investing in companies that are a part of the mid cap stocks list are:
  • Mid caps have a lower risk and volatility when compared to small cap funds, but a higher growth potential than large cap stocks.
  • They are underfollowed in stock markets as compared to large cap stocks, giving a huge opportunity to investors to uncover hidden opportunities. If chosen well, and the stock grows rapidly, its share price will get a further boost as mutual funds and institutional investors eventually take notice.
  • Mid cap stocks most often outperform large caps in bull markets, as they have more growth potential from opportunities that emerge during strong economies. Because of this, a mid-cap stock can grow into a large-cap stock if the business performs well.
The process of choosing best mid cap stocks for investment does not entirely differ from that involved in choosing other stocks. You can follow the simple approach mentioned in our investment guide here.

It does, however, warrant extra caution (like a higher margin of safety) due to the higher risk you take by investing in small cap companies.

Mid cap stocks are considered to be more risky than large cap stocks by virtue of being more volatile. Though this in itself is not a problem, this makes midcaps unsuitable for people with conservative/moderate risk profiles.

Mid-cap stocks are more at risk during downturns. They simply don't have the same resources as larger companies. Example, they can't borrow money as easily as big companies, don't have as much cash on hand, and are more likely to have negative cash flow. Therefore, they have a greater chance of going bankrupt during a market crash.

However, they also have a higher growth potential and often outperform large caps in bull markets.

You can use different criterias to arrive at the list of best stocks in the Mid Cap company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Mid Cap companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Procter & Gamble Hygiene and Health Care Ltd. (M) Very Good 13,604 44,158 61.68 46.69 40.31 79.20
Colgate-Palmolive (India) Ltd. (M) Very Good 2,391 65,034 44.49 32.92 29.84 74.48
Tata Communications Ltd. (M) Very Good 1,578 44,980 40.26 22.24 12.10 68.26
Inventurus Knowledge Solutions Ltd. (S) Very Good 1,548 26,163 77.66 7.58 61.08 46.20
Gillette India Ltd. (S) Very Good 8,020 26,134 55.13 24.10 34.82 42.84

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Mazagon Dock Shipbuilders Ltd. (M) Very Good 2,679 1,06,627 184.1
One97 Communications Ltd. (S) Somewhat Good 803.0 49,978 94.55
Coromandel International Ltd. (M) Very Good 1,980 58,339 84.03
Dixon Technologies (India) Ltd. (M) Very Good 13,608 79,389 76.18
Muthoot Finance Ltd. (M) Very Good 2,382 95,621 61.13
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
OLA Electric Mobility Ltd. (M) Not Good 54.86 23,364 0.00 2.11 -1099.31 282.2
Vishal Mega Mart Ltd. - Somewhat Good 103.6 47,905 104.0 3.71 36.53 51.66
KPIT Technologies Ltd. (M) Very Good 1,325 35,846 47.21 13.29 26.56 50.01
FSN E-Commerce Ventures Ltd. (M) Somewhat Good 176.8 51,195 970.9 38.44 113.2 40.68
IDFC First Bank Ltd. (M) Somewhat Good 55.16 40,235 20.88 1.07 11.05 36.59

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Vishal Mega Mart Ltd. - Somewhat Good 103.6 47,905 104.0 3.71 36.53 82.06
Kalyan Jewellers India Ltd. (M) Somewhat Good 477.8 48,184 75.92 10.56 37.19 75.71
Jindal Stainless Ltd. (M) Very Good 581.4 47,894 19.83 2.97 10.66 64.86
Linde India Ltd. (M) Somewhat Good 6,250 53,306 122.8 14.56 64.82 61.53
Patanjali Foods Ltd. (M) Somewhat Good 1,809 65,500 57.00 5.84 32.92 51.50
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...